Associated Papers
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-α Receptor-Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network.
Gaggiano C et al.
Mediators of Inflammation, 2020
Tumour necrosis factor receptor-associated periodic syndrome mimicking chronic spontaneous urticaria.
Aurich S et al.
Journal of the European Academy of Dermatology and Venereology : Jeadv, 2017
Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study.
Bulua AC et al.
Arthritis and Rheumatism, 2012
Differential cytokine secretion results from p65 and c-Rel NF-κB subunit signaling in peripheral blood mononuclear cells of TNF receptor-associated periodic syndrome patients.
Nedjai B et al.
Cellular Immunology, 2011
MEFV, TNF1rA, CARD15 and NLRP3 mutation analysis in PFAPA.
Dagan E et al.
Rheumatology International, 2010
TNF receptor-associated periodic syndrome (TRAPS): a new cause of joint destruction?
Schoindre Y et al.
Joint Bone Spine, 2009
The tumour necrosis factor receptor-associated periodic syndrome: current concepts.
Stojanov S et al.
Expert Reviews in Molecular Medicine, 2005
The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.
Hull KM et al.
Medicine, 2002
MEFV, TNFRSF1A and CARD15 mutation analysis in Behçet's disease.
Baruch Y et al.
Clinical and Experimental Rheumatology, 0
Select a paper to view details